Cargando…

STAT5 acetylation: Mechanisms and consequences for immunological control and leukemogenesis

The cytokine-inducible transcription factors signal transducer and activator of transcription 5A and 5B (STAT5A and STAT5B) are important for the proper development of multicellular eukaryotes. Disturbed signaling cascades evoking uncontrolled expression of STAT5 target genes are associated with can...

Descripción completa

Detalles Bibliográficos
Autores principales: Kosan, Christian, Ginter, Torsten, Heinzel, Thorsten, Krämer, Oliver H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876427/
https://www.ncbi.nlm.nih.gov/pubmed/24416653
http://dx.doi.org/10.4161/jkst.26102
_version_ 1782297485986758656
author Kosan, Christian
Ginter, Torsten
Heinzel, Thorsten
Krämer, Oliver H
author_facet Kosan, Christian
Ginter, Torsten
Heinzel, Thorsten
Krämer, Oliver H
author_sort Kosan, Christian
collection PubMed
description The cytokine-inducible transcription factors signal transducer and activator of transcription 5A and 5B (STAT5A and STAT5B) are important for the proper development of multicellular eukaryotes. Disturbed signaling cascades evoking uncontrolled expression of STAT5 target genes are associated with cancer and immunological failure. Here, we summarize how STAT5 acetylation is integrated into posttranslational modification networks within cells. Moreover, we focus on how inhibitors of deacetylases and tyrosine kinases can correct leukemogenic signaling nodes involving STAT5. Such small molecules can be exploited in the fight against neoplastic diseases and immunological disorders.
format Online
Article
Text
id pubmed-3876427
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-38764272014-01-10 STAT5 acetylation: Mechanisms and consequences for immunological control and leukemogenesis Kosan, Christian Ginter, Torsten Heinzel, Thorsten Krämer, Oliver H JAKSTAT Review The cytokine-inducible transcription factors signal transducer and activator of transcription 5A and 5B (STAT5A and STAT5B) are important for the proper development of multicellular eukaryotes. Disturbed signaling cascades evoking uncontrolled expression of STAT5 target genes are associated with cancer and immunological failure. Here, we summarize how STAT5 acetylation is integrated into posttranslational modification networks within cells. Moreover, we focus on how inhibitors of deacetylases and tyrosine kinases can correct leukemogenic signaling nodes involving STAT5. Such small molecules can be exploited in the fight against neoplastic diseases and immunological disorders. Landes Bioscience 2013-10-01 2013-08-19 /pmc/articles/PMC3876427/ /pubmed/24416653 http://dx.doi.org/10.4161/jkst.26102 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Review
Kosan, Christian
Ginter, Torsten
Heinzel, Thorsten
Krämer, Oliver H
STAT5 acetylation: Mechanisms and consequences for immunological control and leukemogenesis
title STAT5 acetylation: Mechanisms and consequences for immunological control and leukemogenesis
title_full STAT5 acetylation: Mechanisms and consequences for immunological control and leukemogenesis
title_fullStr STAT5 acetylation: Mechanisms and consequences for immunological control and leukemogenesis
title_full_unstemmed STAT5 acetylation: Mechanisms and consequences for immunological control and leukemogenesis
title_short STAT5 acetylation: Mechanisms and consequences for immunological control and leukemogenesis
title_sort stat5 acetylation: mechanisms and consequences for immunological control and leukemogenesis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876427/
https://www.ncbi.nlm.nih.gov/pubmed/24416653
http://dx.doi.org/10.4161/jkst.26102
work_keys_str_mv AT kosanchristian stat5acetylationmechanismsandconsequencesforimmunologicalcontrolandleukemogenesis
AT gintertorsten stat5acetylationmechanismsandconsequencesforimmunologicalcontrolandleukemogenesis
AT heinzelthorsten stat5acetylationmechanismsandconsequencesforimmunologicalcontrolandleukemogenesis
AT krameroliverh stat5acetylationmechanismsandconsequencesforimmunologicalcontrolandleukemogenesis